T1	intervention 119 128	denosumab
T2	control 136 151	zoledronic acid
T4	outcome 987 990	SRE
T5	iv-bin-percent 992 995	31%
T6	cv-bin-percent 1000 1003	36%
T8	iv-bin-percent 1062 1065	12%
T9	iv-bin-abs 1071 1074	123
T10	cv-bin-percent 1098 1101	16%
T11	cv-bin-abs 1107 1110	162
T3	condition 0 46	Bone-related complications and quality of life
T7	outcome 1021 1057	incidence of first radiation to bone
T15	outcome 1453 1473	improvement in HRQoL
T16	iv-bin-percent 1399 1410	Ten percent
T17	intervention-participants 547 552	1,026
T18	control-participants 620 625	1,020
T12	outcome 1158 1189	time to first radiation to bone
T13	outcome 1301 1349	time to first SRE or hypercalcemia of malignancy
